We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+14.13%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$24.4B
AUM Growth
+$627M
Cap. Flow
-$540M
Cap. Flow %
-2.21%
Top 10 Hldgs %
48.29%
Holding
168
New
24
Increased
37
Reduced
33
Closed
24

Top Buys

Rank Stock Value
1
ETHA
iShares Ethereum Trust ETF
ETHA
+$221M
2
WAB icon
Wabtec
WAB
+$177M
3
K
Kellanova
K
+$173M
4
NSC icon
Norfolk Southern
NSC
+$171M
5
EXEL icon
Exelixis
EXEL
+$139M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$3.53B
2
HES
Hess
HES
+$804M
3
IQV icon
IQVIA
IQV
+$530M
4
LBRDK icon
Liberty Broadband Class C
LBRDK
+$421M
5
ANSS
Ansys
ANSS
+$350M

Sector Composition

Rank Sector Weight
1 Healthcare 33.14%
2 Technology 11.51%
3 Financials 9.33%
4 Communication Services 4.99%
5 Industrials 4.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TECX
76
Tectonic Therapeutic
TECX
$606M
$10M 0.04%
640,000
-213,050
-25% -$4.4M
SVRA icon
77
Savara
SVRA
$1.19B
$8.93M 0.04%
2,500,000
-4,335,000
-63% -$12.8M
NVAX icon
78
Novavax
NVAX
$1.31B
$6.76M 0.03%
780,000
+764,000
+4,775% +$5.95M
SDGR icon
79
Schrodinger
SDGR
$1.36B
$5.7M 0.02%
284,000
-822,000
-74% -$16.5M
SOXX icon
80
iShares Semiconductor ETF
SOXX
$45.9B
$5.13M 0.02%
+18,907
New +$4.72M
ALE
81
DELISTED
Allete
ALE
$4.98M 0.02%
+75,000
New +$4.87M
TVRD
82
Tvardi Therapeutics
TVRD
$23.4M
$1.68M 0.01%
43,225
– –
ALVO icon
83
Alvotech
ALVO
$1.29B
$1.64M 0.01%
199,675
– –
MDGL icon
84
Madrigal Pharmaceuticals
MDGL
$11.8B
$1.52M 0.01%
3,319
– –
SMC
85
Summit Midstream
SMC
$419M
$1.2M ﹤0.01%
58,214
– –
BTSG icon
86
BrightSpring Health Services
BTSG
$12.4B
$650K ﹤0.01%
22,000
– –
ALKS icon
87
Alkermes
ALKS
$8.25B
$624K ﹤0.01%
20,800
-670,863
-97% -$18.9M
ROIV icon
88
Roivant Sciences
ROIV
$26.2B
$560K ﹤0.01%
37,000
– –
ARWR icon
89
Arrowhead Research
ARWR
$12.4B
$545K ﹤0.01%
15,800
– –
WGS icon
90
GeneDx Holdings
WGS
$2.3B
$539K ﹤0.01%
5,000
-321,677
-98% -$35M
GH icon
91
Guardant Health
GH
$22.6B
$500K ﹤0.01%
8,000
– –
ARQT icon
92
Arcutis Biotherapeutics
ARQT
$3.18B
$490K ﹤0.01%
26,000
– –
AXSM icon
93
Axsome Therapeutics
AXSM
$10.9B
$486K ﹤0.01%
4,000
– –
HQY icon
94
HealthEquity
HQY
$8.75B
$474K ﹤0.01%
5,000
-314,800
-98% -$29.6M
INSM icon
95
Insmed
INSM
$28.6B
$432K ﹤0.01%
3,000
– –
PGNY icon
96
Progyny
PGNY
$2.2B
$387K ﹤0.01%
18,000
– –
ONC
97
BeOne Medicines Ltd
ONC
$39.4B
$375K ﹤0.01%
1,100
– –
KRYS icon
98
Krystal Biotech
KRYS
$9.66B
$353K ﹤0.01%
2,000
– –
ACLX
99
DELISTED
Arcellx
ACLX
$328K ﹤0.01%
4,000
– –
CGON icon
100
CG Oncology
CGON
$6.66B
$322K ﹤0.01%
8,000
– –
2 3
4
5 6

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Farallon Capital Management held 168 positions worth $24.4B, up 2.6% from $23.8B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Farallon Capital Management's Q3 2025 filing shows 24 new, 37 increased, 33 reduced and 24 closed positions. Its largest new stake was iShares Ethereum Trust ETF: 7,450,730 shares worth $235M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $3.53B.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 33% a quarter earlier, followed by Technology and Financials.

  • Farallon Capital Management's largest Q3 2025 buy was iShares Ethereum Trust ETF: 7,450,730 shares worth $235M.
  • Farallon Capital Management added most to Wabtec in Q3 2025, an estimated $177M increase.
  • Farallon Capital Management's biggest Q3 2025 reduction was IQVIA, cutting an estimated $530M.
  • Farallon Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q3 2025, selling an estimated $3.53B.
  • Farallon Capital Management's ten largest holdings make up 48% of its $24.4B portfolio in Q3 2025.
  • Farallon Capital Management opened 24 new positions and closed 24 in Q3 2025.
  • Farallon Capital Management's portfolio value rose 2.6% quarter-over-quarter to $24.4B.

Based on Farallon Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.